$BLMH On Track To Reach Guidance So Far I’m looking forward to seeing updates from Bloom Health Partners (CSE: BLMH) to see if they are still maintaining their 2022 guidance of C$25M-C$28M in revenue. The company reported $5.8M in revenue for Q1, which is more their half the company’s current valuation, so I’m pretty optimistic.
Just based on $BLMH.c’s 2021 revenue of $9.8M, this is already a huge indicator the company is successfully executing its growth initiatives. With $BLMH.c currently on track to at least 2.5x its revenue YOY, I’m surprised shares are continuing to trade at all-time lows.
There haven’t been many updates from the company following the announcement of the appointment of a new COO, so I am interested to see what the company has been working on for the past month.
$BLMH.c is currently trading at $.24 and is valued at $9.8M.
https://ceo.ca/@newsfile/bloom-health-partners-appoints-seasoned-healthcare